EE+ POEM Archive
Abelacimab prevents asymptomatic clots better than enoxaparin, but there is no difference in clinical clots or major bleeding
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Abelacimab Prevents Asymptomatic Clots Better Than Enoxaparin, but There Is No Difference in Clinical Clots or Major Bleeding." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315467/all/Abelacimab_prevents_asymptomatic_clots_better_than_enoxaparin__but_there_is_no_difference_in_clinical_clots_or_major_bleeding.
Abelacimab prevents asymptomatic clots better than enoxaparin, but there is no difference in clinical clots or major bleeding. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315467/all/Abelacimab_prevents_asymptomatic_clots_better_than_enoxaparin__but_there_is_no_difference_in_clinical_clots_or_major_bleeding. Accessed October 13, 2024.
Abelacimab prevents asymptomatic clots better than enoxaparin, but there is no difference in clinical clots or major bleeding. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315467/all/Abelacimab_prevents_asymptomatic_clots_better_than_enoxaparin__but_there_is_no_difference_in_clinical_clots_or_major_bleeding
Abelacimab Prevents Asymptomatic Clots Better Than Enoxaparin, but There Is No Difference in Clinical Clots or Major Bleeding [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 October 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315467/all/Abelacimab_prevents_asymptomatic_clots_better_than_enoxaparin__but_there_is_no_difference_in_clinical_clots_or_major_bleeding.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Abelacimab prevents asymptomatic clots better than enoxaparin, but there is no difference in clinical clots or major bleeding
ID - 1315467
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315467/all/Abelacimab_prevents_asymptomatic_clots_better_than_enoxaparin__but_there_is_no_difference_in_clinical_clots_or_major_bleeding
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
